The veterinary orthopedic medicine market has seen considerable growth due to a variety of factors.
• The veterinary orthopedic medicine market has seen strong growth in recent years. It will increase from $3.69 billion in 2024 to $4.04 billion in 2025, with a CAGR of 9.5%.
This growth is due to the emergence of regenerative medicine, the integration of telemedicine, a rising number of veterinary orthopedic specialists, an increased adoption of viscosupplementation products, and improved awareness of animal health.
The veterinary orthopedic medicine market is expected to maintain its strong growth trajectory in upcoming years.
• The veterinary orthopedic medicine market is projected to reach $5.74 billion by 2029 at a CAGR of 9.2%.
This growth is driven by the increasing prevalence of osteoarthritis, rising adoption of pet insurance, high obesity rates in companion animals, growing pet ownership, and increased spending on pets. Major trends include hybrid implants, advanced materials, regenerative medicine, 3D imaging, and CT scanning.
The growth of the veterinary orthopedic medicine market is anticipated to be fueled by the escalating occurrence of orthopedic diseases in pets. These ailments impact the musculoskeletal system of companion animals, primarily dogs and cats. Breed predispositions, escalating obesity rates, and environmental elements such as insufficient exercise and inadequate nutrition are notable factors contributing to the rise in pet orthopedic diseases. Veterinary orthopedic medicine plays a pivotal role in the diagnosis, treatment, and management of these ailments, helping animals to relieve pain, regain mobility, and enhance their overall quality of life. For example, the Morris Animal Foundation, a non-profit organization based in the US, reported that in July 2024, more than 14 million adult dogs in the US were suffering from osteoarthritis. Furthermore, evidence suggests that about 90% of cats over 12 years old show radiographic evidence of osteoarthritis. This highlights the high incidence of this disease in aging pets and underscores the mounting necessity for awareness and advancements in treatment options. Consequently, the veterinary orthopedic medicine market is experiencing growth due to the rising occurrence of pet orthopedic diseases.
The veterinary orthopedic medicine market covered in this report is segmented –
1) By Product: Biologics, Viscosupplements, Pharmaceuticals
2) By Animal Type: Canine, Feline, Equine, Cattle, Swine, Other Animal Types
3) By Application: Osteoarthritis, Degenerative Joint Disease, Joint Inflammation Or Pain, Other Applications
4) By End-use: Veterinary Hospitals, Veterinary Clinics, Other End Users
Subsegments:
1) By Biologics: Platelet-Rich Plasma (PRP), Stem Cell Therapy, Bone Marrow Aspirate Concentrate (BMAC), Viscosupplements
2) By Viscosupplements: Hyaluronic Acid, Corticosteroid Injections
3) By Pharmaceuticals: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Analgesics, Antibiotics
Leading companies in the veterinary orthopedic medicine sector are channeling their resources into innovative technologies such as a 3D printing lab that accommodates custom implants, cell regeneration therapies, including stem cell and platelet-rich plasma (PRP) treatments, as well as ground-breaking imaging methods like CT scans and MRIs engineered specifically for animals. A 3D Printing Lab for animal orthopedic surgical procedures is an expert facility employing 3D printing innovations to manufacture custom implants, prosthetics, and surgical equipment specially developed for veterinary orthopedic operations. For instance, in October 2024, VCA Animal Hospitals, an American company providing high-quality pet care, inaugurated a 3D printing lab at its VCA Northwest Veterinary Specialists center in Clackamas, Oregon. The lab uses sophisticated 3D printing technology with an objective to elevate orthopedic surgical procedures for pets, by producing custom implants and surgical guides personalized for each pet's unique anatomical structure. Osteoarthritis, afflicting 20% of dogs only a year old and 80% of dogs over eight years old, often requires surgical solutions. By adopting this unique approach, VCA aims for quicker recovery periods and enhanced surgical results, tackling intricate orthopedic problems more efficaciously than conventional methods.
Major companies operating in the veterinary orthopedic medicine market are:
• AmerisourceBergen Corporation
• Johnson & Johnson
• EVEROST Inc.
• Zoetis Inc.
• Elanco Animal Health
• Integra lifesciences
• Ceva Sante Animale
• Virbac SA
• STERIS Animal Health
• Merck Animal Health (Merck & Co. Inc.)
• Veterinary Orthopedic Implants
• American Regent
• Bimeda U.S.
• B. Braun Melsungen AG
• Coveto SA
• Biogenesis Bago
• Vetoquinol S.A.
• Avante Animal Health
• Hyalogic LLC
• Hester Biosciences
• Petline Sa
• Sklar Instruments
• GerMedUSA
• RWD Life Science
• Orthomed (UK) Ltd.
• BioMedtrix LLC
• IMEX Veterinary Inc.
North America was the largest region in the veterinary orthopedic medicine market in 2023. The regions covered in the veterinary orthopedic medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.